Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease

NCT01971164 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia of Chronic Kidney Disease

Interventions

DRUG: JTZ-951
DRUG: Placebo

Sponsor

Akros Pharma Inc.